A- A A+

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program. 

Ward KM, Scheim A, Wang J, Cocchiaro B, Singley K, Roth AM. 

Drug Alcohol Depend Rep. 2022 Jun;3:100055. doi: 10.1016/j.dadr.2022.100055. Epub 2022 Apr 26. PMID: 35497489; PMCID: PMC9040407.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040407/